(Alliance News) - GSK PLC on Tuesday said the World Health Organisation made it easier for its malaria vaccine Mosquirix to be rolled out while the US Food & Drug Administration is reviewing the firm's kidney disease drug, daprodustat. Read More
(Alliance News) - Biopharma firm GSK PLC on Thursday said it will present new data on its ovarian cancer and endometrial cancer drugs from September 9 to 13 at the European Society for Medical Oncology Congress 2022 in Paris. Read More
(Alliance News) - The FTSE 100 managed to outperform European counterparts on Friday due to weakness in the pound as consumer confidence in the UK fell to a record low, while attention turns to next week's Jackson Hole Symposium. Read More
(Alliance News) - London's FTSE 100 outperformed peers but was unable to stave off selling pressure in a tough session for European stocks on Friday, despite sitting just above positive territory for much of the late-morning's trade. Read More
(Alliance News) - GSK PLC on Wednesday said the US Food & Drug Administration has accepted the new drug application for its momelotinib, which could potentially treat a rare blood cancer myelofibrosis. Read More
(Alliance News) - GSK PLC on Tuesday said it has completed the acquisition of Massachusetts-based clinical-stage biopharmaceutical company Affinivax Inc. Read More
(Alliance News) - The FTSE 100 ended a largely positive week on solid footing, with markets on Friday continuing to digest some encouraging inflation figures in the US. Read More
(Alliance News) - Stock prices in London were slightly higher at midday on Friday with markets trading on optimism about US inflation, which is showing signs of easing. Read More
(Alliance News) - Shares in GSK PLC and its consumer healthcare spin-off Haleon PLC have seen a rough couple of days in London, as the pair, alongside peers Pfizer Inc and Sanofi SA, stare down a daunting litigation claim. Read More
(Alliance News) - Stock prices in London opened mixed on Friday with Flutter Entertainment leading the FTSE 100, while pharmaceutical companies responded to market concerns about litigation over withdrawn heartburn treatment Zantac. Read More
(Alliance News) - Pfizer late Thursday said it has "significant defences" against Zantac litigation, while Haleon revealed it is "not a party" to any claims. Read More
(Alliance News) - Pfizer Inc late Thursday said it has "significant defences" against Zantac litigation, while Haleon PLC revealed it is "not a party" to any claims. Read More
(Alliance News) - Equities in London failed to sustain gains into Thursday despite further data showing price pressures may finally be easing in the US. Read More
(Alliance News) - Stock prices in London were mostly lower at midday on Thursday as a rally fuelled by cooling US inflation lost steam, while Walt Disney shares surged in New York after posting huge subscriber growth. Read More
